Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Lea S, Blaser"'
Autor:
Lea S Blaser, Urs Duthaler, Jamal Bouitbir, Anne B Leuppi-Taegtmeyer, Evangelia Liakoni, Reto Dolf, Michael Mayr, Jürgen Drewe, Stephan Krähenbühl, Manuel Haschke
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Aim: The objective was to investigate the effect of metamizole on renal function in healthy, salt-depleted volunteers. In addition, the pharmacokinetics of the four major metamizole metabolites were assessed and correlated with the pharmacodynamic ef
Externí odkaz:
https://doaj.org/article/90f5c5c6045e47539c09d00108323638
Autor:
Christine Bernsmeier, Anne C Meyer-Gerspach, Lea S Blaser, Lia Jeker, Robert E Steinert, Markus H Heim, Christoph Beglinger
Publikováno v:
PLoS ONE, Vol 9, Iss 1, p e87488 (2014)
The incretins glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) are gastrointestinal peptide hormones regulating postprandial insulin release from pancreatic β-cells. GLP-1 agonism is a treatment strategy in Type
Externí odkaz:
https://doaj.org/article/1cbbb0e34ee14a52a39df29061d70013
Autor:
Lea S. Blaser, Alexandra E. Rätz Bravo, Sarah Hofmann, Andreas Holbro, Manuel Haschke, Stephan Krähenbühl, Hala Hassna, Anne B. Taegtmeyer, Andreas Zeller
Publikováno v:
Blaser, Lea; Hassna, Hala; Hofmann, Sarah; Holbro, Andreas; Haschke, Manuel Martin; Rätz Bravo, Alexandra; Zeller, Andreas; Krähenbühl, Stephan; Taegtmeyer, Anne (2017). Leucopenia associated with metamizole: a case-control study. Swiss medical weekly, 147, w14438. EMH Schweizerischer Ärzteverlag 10.4414/smw.2017.14438
AIMS OF THE STUDY The aim of this study was to identify possible risk factors for the development of leucopenia associated with metamizole use. METHODS A retrospective case-control study was performed. Cases of metamizole-associated leucopenia manage
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::904b6173672584f7f87b54c6f85efd62
https://pubmed.ncbi.nlm.nih.gov/33378544
https://pubmed.ncbi.nlm.nih.gov/33378544
Publikováno v:
Bioanalysis. 12(3)
Aim: Metamizole is a frequently used antipyretic and analgesic prodrug, yet its pharmacokinetics has not been thoroughly studied in infants and with coadministered medications. Thus, an LC–MS/MS method was developed to quantify the four major metam
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34bf1ff346f750105254ab7c66e30e0a
https://pubmed.ncbi.nlm.nih.gov/32052638
https://pubmed.ncbi.nlm.nih.gov/32052638
Publikováno v:
Praxis. 104:151-154
We present the case of a 63 year old man who died of severe septic shock in the setting of agranulocytosis induced by dipyrone (metamizole). The patient had previously developed agranulocytosis after dipyrone exposure 18 months prior to this. The cas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0298be2474545b6a2238dc4ee0b6b139
https://doi.org/10.1024/1661-8157/a001916
https://doi.org/10.1024/1661-8157/a001916
Publikováno v:
Praxis. 104(3)
We present the case of a 63 year old man who died of severe septic shock in the setting of agranulocytosis induced by dipyrone (metamizole). The patient had previously developed agranulocytosis after dipyrone exposure 18 months prior to this. The cas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::02c597f9ea1f1ea9e53a00462f3ac178
https://pubmed.ncbi.nlm.nih.gov/25626384
https://pubmed.ncbi.nlm.nih.gov/25626384
Autor:
Manuel Haschke, Lea S. Blaser, Alexandra Tramonti, Pascal Egger, Stephan Krähenbühl, Alexandra E. Rätz Bravo
Publikováno v:
European journal of clinical pharmacology. 71(2)
Purpose: Since the 1970s, the use of metamizole is controversial due to the risk of agranulocytosis. The aim of this study was to analyze individual case safety reports (ICSRs) of metamizole-associated hematological adverse drug reactions (ADRs). Met
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::457ae4c412d6878229149ff9cb92841f
https://pubmed.ncbi.nlm.nih.gov/25401171
https://pubmed.ncbi.nlm.nih.gov/25401171
Autor:
Lea S. Blaser, Christine Bernsmeier, Anne Christin Meyer-Gerspach, Markus H. Heim, Robert E. Steinert, Lia Jeker, Christoph Beglinger
Publikováno v:
PLoS ONE
PLoS ONE, Vol 9, Iss 1, p e87488 (2014)
PLoS ONE, Vol 9, Iss 1, p e87488 (2014)
BACKGROUND & AIMS: The incretins glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) are gastrointestinal peptide hormones regulating postprandial insulin release from pancreatic β-cells. GLP-1 agonism is a treatme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6c0d7da501abef290288b1ef5cc2af6
https://lirias.kuleuven.be/handle/123456789/624531
https://lirias.kuleuven.be/handle/123456789/624531
